A Phase I Study of SHR -2001 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 19, 2023

Primary Completion Date

November 20, 2024

Study Completion Date

November 20, 2024

Conditions

Healthy

Interventions

DRUG

SHR-2001

Subcutaneous injection, single dose or multiple doses.

DRUG

Placebo

Subcutaneous injection, single dose or multiple doses.

Trial Locations (1)

The Affiliated Hospital of Qingdao University, Qingdao

All Listed Sponsors

lead

Guangdong Hengrui Pharmaceutical Co., Ltd

INDUSTRY